【作者】 黄宗宣；

【导师】 严媚；

【作者基本信息】 新疆医科大学 ， 儿科学， 2011， 硕士

【摘要】 目的：探讨黄芪注射液对急性淋巴细胞白血病化疗患儿造血功能和免疫功能的影响。方法：63例均处于初治诱导缓解治疗阶段的急性淋巴细胞白血病患儿随机分为治疗组31例和对照组32例,治疗组在化疗同时给予黄芪注射液0.5～1ml/kg/d,共35天,对照组单用化疗,两组其他支持治疗相同。观察两组化疗后完全缓解率,化疗前后WBC、RBC、HB、PLT, T淋巴细胞亚群CD3+、CD4+ CD8+、CD4+/CD8+比值、和NK细胞的水平,感染及抗生素应用天数。结果：化疗后完全缓解率治疗组[84%(26/31)]与对照组[75%(24/32)]比较,差异无统计学意义(P>0.05)；化疗后治疗组外周血血小板计数和血红蛋白均高于对照组,差异有统计学意义(P<0.05)；化疗后两组CD3+、CD4+、CD8+明显高于化疗前,差异有统计学意义(P<0.05)；化疗后治疗组CD3+、CD4+/CD8+比值明显高于对照组,差异有统计学意义(P<0.05)；化疗期间并发感染在使用抗生素天数方面治疗组明显少于对照组,两组比较差异有统计学意义(P<0.05)。结论：黄芪注射液能减轻化疗对急性淋巴细胞白血病患儿骨髓造血功能的抑制,并能促进化疗患儿骨髓造血功能的恢复；提高化疗患儿的细胞免疫功能；且化疗期间并发感染的程度轻,抗生素应用天数少,感染容易得到控制,可改善急性白血病化疗患儿的生活质量。更多还原

【Abstract】 Objective:To investigate the effect of A.membranceus injection for hemopoietic and immune function reconstruction in children with acute leukemia after chemotherapy. Methods:Sixty-three leukemia children at remission inducing stage of initial treatment were randomly assigned to two groups,the reatment group treated with A.membranceus (0.5～1ml/kg/daily)plus chenmotherapy and the contorl group only treated with chemotherapy for 35 days,with same supportive treatments administered to both.Levels of blood routine test,T lymphocyte subsets(CD3+ CD4+、CD8+、CD4+/CD8+)and NK cell were detemined before and after treatment, and the remission rate was assessed after treatment.Results:The remission rates in the two groups showed no significant difference[84%(26/31) vs 75%(24/32),(P>0.05)] statistically.Levels of peripheral leucocyte count and hemoglobin as well as levels of CD3+、CD4+/CD8+ were significantly higher in the treatment group than in the control group (P<0.05),but no significant difference was shown between groups in CD4+、CD8+、NK cell level. Conclusion:A.membranceus can lighten the inhibition of chemotherapy on hemopoietic function of pone marrow and promote its recovery,enhance the immune function, Moreover the patients of the A.membranceus treated group suffered fewer infections which could be controlled more easily also with decreased administration days of antibioticse and improve the quality of life in atients with acute leukemia undergoing chemotherapy.更多还原